Biden Says US Ready To Share COVID-19 Vaccine Related Technology
Biden Says US Ready To Share COVID-19 Vaccine Related Technology
拜登稱美國準備分享新冠肺炎疫苗相關技術
- President Joe Biden said that the U.S. will share technologies used to make COVID-19 vaccines through the World Health Organization and is working on expanding rapid testing and antiviral treatments for hard-to-reach populations.
- "We are making available health technologies that are owned by the United States government, including stabilized spike protein that is used in many COVID-19 vaccines," Biden said in his opening speech.
- It has gathered more than $3 billion in new funding to fight the pandemic, the White House said, including over $2 billion for immediate response and $962 million in commitments to the World Bank pandemic preparedness fund.
- Biden has asked Congress for over $22.5 billion in additional COVID-19 response funds, including $5 billion for international aid. Lawmakers have failed to pass any funding bill, and those negotiating the package have been unable to agree on how to pay for the global response.
- The U.S. National Institutes will license the technologies for Health to the WHO's COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP).
- Scientists at the NIH worked with Moderna Inc (NASDAQ: MRNA) to develop its COVID-19 shot.
美國總統喬·拜登表示,美國將通過世界衞生組織分享製造新冠肺炎疫苗的技術,並正在努力為難以接觸到的人羣擴大快速檢測和抗病毒治療。
拜登在開幕詞中説,“我們正在提供美國政府擁有的醫療技術,包括用於許多新冠肺炎疫苗的穩定的尖峯蛋白。”
白宮表示,它已經籌集了超過30億美元的新資金來抗擊大流行,其中包括20多億美元用於立即應對,以及9.62億美元對世界銀行大流行準備基金的承諾。
拜登已經要求國會追加225億美元的新冠肺炎應對資金,其中包括50億美元的國際援助。立法者未能通過任何撥款法案,談判一攬子計劃的人也無法就如何支付全球響應的費用達成一致。
美國國家研究院將把健康技術授權給世界衞生組織的新冠肺炎技術訪問庫(C-TAP)和藥物專利庫(MPP)。
美國國立衞生研究院的科學家們致力於$Moderna(MRNA.US)$開發其新冠肺炎。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
搶先評論
0 0 0
讚好勁正笑哭社會社會Emm惨惨嬲嬲
輕觸選擇心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧
點擊這裡與好友分享
暫無評論,快來留言吧!